The 1996 pertussis epidemic in New Zealand: Vaccine effectiveness

New Zealand Medical Journal

Volumn 112, Issue 1085, 1999, Pages 118-120

  Blakely, Tony A ^a,c   Mansoor, Osman ^b   Baker, Michael ^a  

^a INSTITUTE OF ENVIRONMENTAL SCIENCE AND RESEARCH   (New Zealand)

^b MINISTRY OF HEALTH   (New Zealand)

^c UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

PERTUSSIS VACCINE;

ARTICLE; CAUCASIAN; CHILD; EPIDEMIC; ETHNOLOGY; HOSPITALIZATION; HUMAN; INFANT; NEW ZEALAND; PERTUSSIS; POLYNESIA; PRESCHOOL CHILD; TREATMENT FAILURE;

CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; EUROPEAN CONTINENTAL ANCESTRY GROUP; HOSPITALIZATION; HUMANS; INFANT; NEW ZEALAND; PERTUSSIS VACCINE; POLYNESIA; TREATMENT FAILURE; WHOOPING COUGH;

EID: 0033537732     PISSN: 00288446     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Blakely T, Mansoor O, Baker M. The 1996 pertussis epidemic in New Zealand: descriptive epidemiology. NZ Med J 1999; 112: 30-3.
2. Farrington CP. Estimation of vaccine effectiveness using the screening method. Int J Epidemiol 1993; 22: 742-6.
3. Farrington CP. The measurement and interpretation of age-specific vaccine efficacy. Int J Epidemiol 1992; 21: 1014-20.
4. Fine PEM, Clarkson JA. Reflections on the efficacy of pertussis vaccines. Rev Infect Dis 1987; 9: 866-83.
5. Plotkin SA, Cadoz M. The acellular pertussis vaccine trials: an interpretation. Pediatr Infect Dis J 1997; 16: 508-17.
6. Simondon F, Preziosi MP, Yam A et al. A randomized double-blind trial comparing a two-component acellular to a whole-cell pertussis vaccine in Senegal. Vaccine 1997; 15: 1606-12.
7. Ramsay MEB, Farrington CP, Miller E. Age-specific efficacy of pertussis vaccine during epidemic and non-epidemic periods. Epidemiol Infect 1993; 111: 41-8.
8. Guris D, Strebel PM, Tachdjian R et al. Effectiveness of the pertussis vaccination programme as determined by use of the screening method: United States, 1992-1994. J Infect Dis 1997; 176: 456-63.
9. Mansoor O, Durham G. Does control of pertussis need rethinking? Commun Dis NZ 1991; 91: 43-8.
10. Jenkinson D. Duration of effectiveness of pertussis vaccine: evidence from a 10-year community study. BMJ 1988; 296: 612-4.
11. Schmidtt-Grohe S, Cherry JD, Heininger U et al. Pertussis in German adults. Clin Infect Dis 1995; 21: 860-6.
12. Cheery JD. Historical review of pertussis and the classical vaccine. J Infect Dis 1996; 174 Suppl 3: S359-63.
13. Bell DW, Ford RPK, Slade B et al. Immunisation coverage in Christchurch in a birth cohort. NZ Med J 1997; 110: 440-2.
14. Rainger W, Soloman N, Jones N et al. Immunisation coverage and risk factors for immunisation failure in Auckland and Northland. NZ Public Health Rep 1998; 5: 49-51.
15. McNicholas A, Garrett N et al. Immunisation coverage surveillance using benefit claim data: July - September 1997. Wellington: ESR; 1997.
16. McNicholas A, Baker M. Immunisation coverage in New Zealand, 1995. NZ Public Health Rep 1996; 3: 83-4.
17. McNicholas A, Baker M. Immunisation coverage in New Zealand: ongoing surveillance using benefit claim data. NZ Public Health Rep 1995; 2: 1-3.
18. Essex C, Smale P, Geddis D. Immunisation status and demographic characteristics of New Zealand infants at 1 year and 2 years of age. NZ Med J 1995; 108: 244-6.
19. Stehr-Green P, Briasco C, Baker M, Trotter P. Immunisation coverage in New Zealand: Results of the regional coverage survey in Hawkes Bay. NZ Med J 1992; 105: 277-9.
20. Ramadas D, Moyes C, Ramadas G. Immunisation status of children in the eastern Bay of Plenty. NZ Med J 1992; 105: 378-9.
21. Immunisation coverage in New Zealand: Results of the regional immunisation coverage surveys. Commun Dis NZ 1992; 92 (Suppl 2).